Plans continue to repatriate medical and research radioactive waste
Australia’s nuclear agency ANSTO is continuing to lead planning efforts to repatriate what is called a TN-81 cask of intermediate-level radioactive from the United Kingdom in 2022.
Showing 41 - 60 of 63 results
Australia’s nuclear agency ANSTO is continuing to lead planning efforts to repatriate what is called a TN-81 cask of intermediate-level radioactive from the United Kingdom in 2022.
ANSTO can confirm it has completed its 9th successful export of spent fuel. The spent fuel, from OPAL, ANSTO’s multipurpose reactor, has gone to France for reprocessing.
ANSTO has agreed to participate in an Australian trial of a review of research infrastructure access proposals in which applicants remain anonymous to aid the removal of structural barriers to the career progression of Women in STEM.
ANSTO provides a summary of waste production and consumables for FY2024 - FY2025
ANSTO is an experienced provider of Teacher Professional Development for Australian and International teachers and our courses cover a wide range of topics. Hear from expert speakers, receive new education resources, and develop lessons for your own class.
ANSTO's Chief Nuclear Officer shares insights on the safe management of Australia's nuclear waste.
In Australia and the Southeast Asia basin, the ANSTO facility offers a wide range of unique nuclear-beam techniques for cultural heritage research.
ANSTO’s Lucas Heights campus has an extensive range of specialised facilities and capabilities that are available to assist industry-based professionals in solving problems. Please contact us to discuss how we can assist you. We are open to entering into commercial arrangement with appropriate partners.
ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.
The newly built Medicines Manufacturing Innovation Centre (MMIC), co-located at the Australian Synchrotron at Clayton, was officially opened on Wednesday by the Victorian Deputy Premier and Minister for Medical Research the Hon Ben Carroll.
This scholarship recognises outstanding ability and promise in the field of nuclear science and technology, specifically as it applies to nuclear energy. Successful applicants will demonstrate a history of interest in nuclear energy and a desire to continue this interest.
A dedicated team of radiation specialists from the Australian Nuclear Science and Technology Organisation (ANSTO) are behind the successful detection and rapid retrieval of a missing radioactive source in outback Western Australia.
The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.
The ARC Centre of Excellence (CoE) for Green Electrochemical Transformation of Carbon Dioxide, GETCO2, will support innovative approaches to carbon capture.
The Titan Krios cryo-electron microscope reveals the inner workings of life at the cellular level.
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
The celebration of the UN’s International Women’s Day 2023 has a theme that highlights the power of innovative IT to combat discrimination and the marginalisation of women globally.
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.